Search Results

Sensorion Reports New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs.

• Source: Entertainment Close-up. 2024.

Record details

Sensorion Reports New Positive Clinical Data Across its Gene Therapy and Small Molecule Programs.

• Source: Manufacturing Close-Up. 2024.

Record details

[CAR-T cells gene therapy medicines: Regulatory status and pharmaceutical circuits in Europe and France].

• Authors : de Jorna R; Université de Paris, AP-HP, hôpital Saint-Louis, pharmacie à Usage Intérieur, 1, avenue Claude Vellefaux, 75010 Paris, France.; Madelaine I

Subjects: Receptors, Chimeric Antigen* ; T-Lymphocytes*/T-Lymphocytes*/T-Lymphocytes*/immunology ; T-Lymphocytes*/T-Lymphocytes*/T-Lymphocytes*/transplantation

• Source: Bulletin du cancer [Bull Cancer] 2021 Oct; Vol. 108 (10S), pp. S162-S167.Publisher: Elsevier Country of Publication: France NLM ID: 0072416 Publication Model: Print Cited Medium: Internet

Record details

The French Society for Cell and Gene Therapy: Our Objectives and Partnerships.

• Authors : Verhoeyen E; French Society for Cell and Gene Therapy, Paris, France.; Gene and Cell Therapy Institute, Paris, France.

Subjects: Genetic Therapy*; France

• Source: Human gene therapy [Hum Gene Ther] 2021 Dec; Vol. 32 (23-24), pp. 1423-1424.Publisher: M.A. Liebert Country of Publication: United States NLM ID: 9008950 Publication Model: Print Cited Medium: Internet ISSN: 1557-7422

Record details

Study Findings on Gene Therapy Described by a Researcher at Universite Paris Cite (Enhanced hepatitis B virus-specific immunity by combined neutralizing antibody therapy and DNA vaccination in a murine model of chronic hepatitis B infection).

• Source: Vaccine Weekly. 2024, pages. 205

Record details

Findings from Universite de Paris Broaden Understanding of Gene Therapy (Comparison of preclinical efficacy of immunotherapies against HPV-induced cancers).

• Source: Vaccine Weekly. 2024, pages. 36

Record details

A Phase 3 Ready DMD Gene Therapy, a Clinical Trial to Offset AAV Neutralizing Antibodies, and an AI Inspired New Generation of Capsids Highlight Genethon's 2024 Fall Milestones.

• Source: Business Wire. 2024.

Record details

Genethon Presents Positive Initial Results from a Phase 1/2/3 Trial of its Gene Therapy (GNT0004) for Duchenne Muscular Dystrophy at ASGCT Breakthroughs in Muscular Dystrophy in Chicago.

• Source: Business Wire. 2024.

Record details

SCORE ONE FOR GENE THERAPY.

• Authors : Licking, Ellen; Carey, John

Subjects: GENE therapy; IMMUNOLOGIC diseases; GENETIC engineeringFRANCE; PARIS (France)

• Source: BusinessWeek. 05/08/2000, Issue 3680, p58-60. 2p. 1 Color Photograph.

Record details

Investigators at National Center for Scientific Research (CNRS) Detail Findings in Gene Therapy (Enhancing Natural Killer Cells Proliferation and Cytotoxicity Using Imidazole-based Lipid Nanoparticles Encapsulating Interleukin-2 Mrna).

• Source: Vaccine Weekly. 2024, pages. 53

Record details